Determinants of COVID-19 vaccination acceptance or hesitancy in Italy: an overview of the current evidence.

IF 1.1 4区医学 Q4 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Annali dell'Istituto superiore di sanita Pub Date : 2023-01-01 DOI:10.4415/ANN_23_01_03

Chiara Primieri, Carla Bietta, Irene Giacchetta, Manuela Chiavarini, Chiara de Waure

{"title":"Determinants of COVID-19 vaccination acceptance or hesitancy in Italy: an overview of the current evidence.","authors":"Chiara Primieri, Carla Bietta, Irene Giacchetta, Manuela Chiavarini, Chiara de Waure","doi":"10.4415/ANN_23_01_03","DOIUrl":null,"url":null,"abstract":"Introduction: Vaccine hesitancy is a major public health issue and a challenge for the implementation of COVID-19 immunization campaigns. The objective of this study was to address the determinants of COVID-19 vaccination acceptance or hesitancy in the Italian population.Materials and methods: We conducted a rapid systematic review by searching PubMed until May 3rd, 2022, according to Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines. Articles assessing determinants of Italians' attitudes towards COVID-19 vaccination in terms of hesitancy and/or acceptance were considered eligible. Quality and risk of bias assessment was performed through the Newcastle Ottawa Scale appraisal tool. Determinants were grouped in three categories: contextual, individual and group, and vaccine/vaccination specific influences.Results: Out of 606 articles, 59 studies were included in the analysis. Included studies demonstrated that, in Italy, COVID-19 vaccination acceptance or hesitancy is mostly influenced by perceived safety, efficacy and usefulness of the vaccine.Conclusion: These findings should be considered to plan tailored interventions for counteracting COVID-19 vaccination hesitancy in Italy.","PeriodicalId":8246,"journal":{"name":"Annali dell'Istituto superiore di sanita","volume":"59 1","pages":"10-25"},"PeriodicalIF":1.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annali dell'Istituto superiore di sanita","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4415/ANN_23_01_03","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 3

Abstract

Introduction: Vaccine hesitancy is a major public health issue and a challenge for the implementation of COVID-19 immunization campaigns. The objective of this study was to address the determinants of COVID-19 vaccination acceptance or hesitancy in the Italian population.

Materials and methods: We conducted a rapid systematic review by searching PubMed until May 3rd, 2022, according to Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines. Articles assessing determinants of Italians' attitudes towards COVID-19 vaccination in terms of hesitancy and/or acceptance were considered eligible. Quality and risk of bias assessment was performed through the Newcastle Ottawa Scale appraisal tool. Determinants were grouped in three categories: contextual, individual and group, and vaccine/vaccination specific influences.

Results: Out of 606 articles, 59 studies were included in the analysis. Included studies demonstrated that, in Italy, COVID-19 vaccination acceptance or hesitancy is mostly influenced by perceived safety, efficacy and usefulness of the vaccine.

Conclusion: These findings should be considered to plan tailored interventions for counteracting COVID-19 vaccination hesitancy in Italy.

查看原文本刊更多论文

意大利COVID-19疫苗接种接受或犹豫的决定因素:当前证据概述

疫苗犹豫是一个重大的公共卫生问题，也是实施COVID-19免疫运动的挑战。本研究的目的是解决意大利人群中COVID-19疫苗接种接受或犹豫的决定因素。材料和方法:根据系统评价首选报告项目(PRISMA)指南，我们通过检索PubMed进行了快速系统评价，直到2022年5月3日。评估意大利人对COVID-19疫苗接种的犹豫和/或接受态度的决定因素的文章被认为是合格的。通过纽卡斯尔渥太华量表评估工具进行质量和偏倚风险评估。决定因素分为三类:环境、个人和群体以及疫苗/疫苗接种的特定影响。结果:606篇文献中，59篇纳入分析。纳入的研究表明，在意大利，COVID-19疫苗接种的接受或犹豫主要受到疫苗的安全性、有效性和有用性的影响。结论:应考虑这些发现，制定有针对性的干预措施，以应对意大利COVID-19疫苗接种犹豫。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annali dell'Istituto superiore di sanita PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

3.80

自引率

4.80%

发文量

审稿时长

>12 weeks

期刊介绍： Annali dell’Istituto Superiore di Sanità is a peer reviewed quarterly science journal which publishes research articles in biomedicine, translational research and in many other disciplines of the health sciences. The journal includes the following material: original articles, reviews, commentaries, editorials, brief and technical notes, book reviews. The publication of Monographic Sections has been discontinued. In case you wish to present a small number of coordinated contributions on specific themes concerning priorities in public health, please contact the Editorial office. The journal is in English.